UK healthtech challenger using AI to cut lung disease test time clinches $19M

A UK healthtech startup which has built AI-powered tech that it says reduces the test time for a lung disease that impacts nearly two million people in the UK from an hour to five minutes has raised $19m in a funding round. Called TidalSense , the startup is looking to transform respiratory diagnosis, starting with COPD (chronic obstructive pulmonary disease). COPD is a chronic lung disease affecting nearly two million people in the UK.